Literature DB >> 30406281

Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation.

Sharad Mangal1, Rongkun Xu1, Heejun Park1, Dmitry Zemlyanov2, Nivedita Shetty1, Yu-Wei Lin3, David Morton4, Hak-Kim Chan5, Jian Li3, Qi Tony Zhou6.   

Abstract

PURPOSE: Dissolution behavior of dry powder inhaler (DPI) antibiotic formulations in the airways may affect their efficacy especially for poorly-soluble antibiotics such as azithromycin. The main objective of this study was to understand the effects of surface composition on the dissolution of spray dried azithromycin powders by itself and in combination with colistin.
METHODS: Composite formulations of azithromycin (a poorly water-soluble molecule) and colistin (a water-soluble molecule) were produced by spray drying. The resultant formulations were characterized for particle size, morphology, surface composition, solid-state properties, solubility and dissolution.
RESULTS: The results demonstrate that surfaces composition has critical impacts on the dissolution of composite formulations. Colistin was shown to increase the solubility of azithromycin. For composite formulations with no surface colistin, azithromycin released at a similar dissolution rate as the spray-dried azithromycin alone. An increase in surface colistin concentration was shown to accelerate the dissolution of azithromycin. The dissolution of colistin from the composite formulations was significantly slower than the spray-dried pure colistin. In addition, FTIR spectrum showed intermolecular interactions between azithromycin and colistin in the composite formulations, which could contribute to the enhanced solubility and dissolution of azithromycin.
CONCLUSIONS: Our study provides fundamental understanding of the effects of surface concentration of colistin on azithromycin dissolution of co-spray-dried composite powder formulations.

Entities:  

Keywords:  aerosol performance; azithromycin; colistin; dissolution; dry powder inhaler; poorly water soluble drug; solubility; spray drying

Mesh:

Substances:

Year:  2018        PMID: 30406281      PMCID: PMC6320342          DOI: 10.1007/s11095-018-2527-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  52 in total

1.  Colistin resistance: a major breach in our last line of defence.

Authors:  David L Paterson; Patrick N A Harris
Journal:  Lancet Infect Dis       Date:  2015-11-19       Impact factor: 25.071

Review 2.  Particle size analysis in pharmaceutics: principles, methods and applications.

Authors:  Boris Y Shekunov; Pratibhash Chattopadhyay; Henry H Y Tong; Albert H L Chow
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

3.  Red-, blue-, or no-shift in hydrogen bonds: a unified explanation.

Authors:  Jorly Joseph; Eluvathingal D Jemmis
Journal:  J Am Chem Soc       Date:  2007-03-22       Impact factor: 15.419

4.  Population pharmacokinetics of colistin methanesulfonate in rats: achieving sustained lung concentrations of colistin for targeting respiratory infections.

Authors:  Shalini Yapa; Jian Li; Christopher J H Porter; Roger L Nation; Kashyap Patel; Michelle P McIntosh
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

5.  Azithromycin retards Pseudomonas aeruginosa biofilm formation.

Authors:  Richard J Gillis; Barbara H Iglewski
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation.

Authors:  Sharad Mangal; Haichen Nie; Rongkun Xu; Rui Guo; Alex Cavallaro; Dmitry Zemlyanov; Qi Tony Zhou
Journal:  Pharm Res       Date:  2018-01-08       Impact factor: 4.200

7.  Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations.

Authors:  Srinivas R B Behara; P Worth Longest; Dale R Farkas; Michael Hindle
Journal:  J Pharm Sci       Date:  2013-12-04       Impact factor: 3.534

8.  Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin.

Authors:  Sabine Favre-Bonté; Thilo Köhler; Christian Van Delden
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

9.  Lung infection--a public health priority.

Authors:  Joseph P Mizgerd
Journal:  PLoS Med       Date:  2006-01-17       Impact factor: 11.069

10.  In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.

Authors:  Seongman Bae; Min-Chul Kim; Su-Jin Park; Hee Sueng Kim; Heungsup Sung; Mi-Na Kim; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim; Yong Pil Chong
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

View more
  6 in total

1.  Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections.

Authors:  Sharad Mangal; Jiayang Huang; Nivedita Shetty; Heejun Park; Yu-Wei Lin; Heidi H Yu; Dmitry Zemlyanov; Tony Velkov; Jian Li; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2019-02-21       Impact factor: 5.875

Review 2.  Physical stability of dry powder inhaler formulations.

Authors:  Nivedita Shetty; David Cipolla; Heejun Park; Qi Tony Zhou
Journal:  Expert Opin Drug Deliv       Date:  2019-12-13       Impact factor: 6.648

3.  Effects of drying method and excipient on structure and stability of protein solids using solid-state hydrogen/deuterium exchange mass spectrometry (ssHDX-MS).

Authors:  Nathan E Wilson; Elizabeth M Topp; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2019-06-25       Impact factor: 5.875

4.  Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa.

Authors:  Shihui Yu; Xiaohui Pu; Maizbha Uddin Ahmed; Heidi H Yu; Tarun Tejasvi Mutukuri; Jian Li; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2021-10-06       Impact factor: 5.875

5.  Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.

Authors:  Vaibhav Pathak; Heejun Park; Dmitry Zemlyanov; Sonal V Bhujbal; Maizbha Uddin Ahmed; Mohammad A K Azad; Jian Li; Qi Tony Zhou
Journal:  Pharm Res       Date:  2022-08-02       Impact factor: 4.580

6.  Surface Composition and Aerosolization Stability of an Inhalable Combinational Powder Formulation Spray Dried Using a Three-Fluid Nozzle.

Authors:  Nivedita Shetty; Yiwen Zhang; Heejun Park; Dmitry Zemlyanov; Dishan Shah; Athena He; Patricia Ahn; Tarun Tejasvi Mutukuri; Hak-Kim Chan; Qi Tony Zhou
Journal:  Pharm Res       Date:  2020-10-09       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.